Healthcare provider profile · identity verified

Crystal Owens, M.D.

Family Medicine · GRAND JUNCTION, CO · NPI 1477676427

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	498	63
Levothyroxine Sodium	Levothyroxine Sodium	495	62
Eliquis	Apixaban	328	43
Lisinopril	Lisinopril	299	43
Gabapentin	Gabapentin	280	34
Furosemide	Furosemide	235	36
Losartan Potassium	Losartan Potassium	212	29
Pantoprazole Sodium	Pantoprazole Sodium	210	33
Metoprolol Succinate	Metoprolol Succinate	179	27
Trazodone Hcl	Trazodone Hcl	177	28
Tamsulosin Hcl	Tamsulosin Hcl	154	16
Amlodipine Besylate	Amlodipine Besylate	153	22
Sertraline Hcl	Sertraline Hcl	151	19
Spironolactone	Spironolactone	145	19
Metformin Hcl	Metformin Hcl	139	23
Potassium Chloride	Potassium Chloride	139	28
Metoprolol Tartrate	Metoprolol Tartrate	137	17
Duloxetine Hcl	Duloxetine Hcl	133	16
Simvastatin	Simvastatin	132	16
Hydrochlorothiazide	Hydrochlorothiazide	127	20
Famotidine	Famotidine	121	25
Omeprazole	Omeprazole	117	22
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	103	14
Carvedilol	Carvedilol	99	13
Rosuvastatin Calcium	Rosuvastatin Calcium	92	11
Escitalopram Oxalate	Escitalopram Oxalate	87	12
Clopidogrel	Clopidogrel Bisulfate	83	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	83	12
Allopurinol	Allopurinol	79	suppressed
Fluticasone Propionate	Fluticasone Propionate	79	17
Quetiapine Fumarate	Quetiapine Fumarate	74	11
Memantine Hcl	Memantine Hcl	73	11
Mirtazapine	Mirtazapine	73	suppressed
Donepezil Hcl	Donepezil Hcl	68	suppressed
Pregabalin	Pregabalin	66	suppressed
Spiriva Respimat	Tiotropium Bromide	63	suppressed
Citalopram Hbr	Citalopram Hydrobromide	58	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	57	28
Bupropion Xl	Bupropion Hcl	55	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	53	suppressed
Baclofen	Baclofen	53	suppressed
Buspirone Hcl	Buspirone Hcl	53	suppressed
Bupropion Hcl Sr	Bupropion Hcl	52	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	51	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	51	17
Jantoven	Warfarin Sodium	50	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	49	suppressed
Latanoprost	Latanoprost	48	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	46	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	45	suppressed
Nystatin	Nystatin	45	15
Ropinirole Hcl	Ropinirole Hcl	45	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	45	suppressed
Alendronate Sodium	Alendronate Sodium	44	suppressed
Pravastatin Sodium	Pravastatin Sodium	44	suppressed
Torsemide	Torsemide	44	suppressed
Cephalexin	Cephalexin	42	19
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	40	suppressed
Dapagliflozin	Dapagliflozin Propanediol	39	suppressed
Ozempic	Semaglutide	39	suppressed
Olanzapine	Olanzapine	38	suppressed
Trulicity	Dulaglutide	37	suppressed
Lamotrigine	Lamotrigine	36	suppressed
Xarelto	Rivaroxaban	36	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	34	suppressed
Montelukast Sodium	Montelukast Sodium	34	suppressed
Paroxetine Hcl	Paroxetine Hcl	34	suppressed
Jardiance	Empagliflozin	33	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	32	suppressed
Levetiracetam	Levetiracetam	32	suppressed
Finasteride	Finasteride	31	suppressed
Topiramate	Topiramate	30	suppressed
Incruse Ellipta	Umeclidinium Bromide	29	suppressed
Lovastatin	Lovastatin	29	suppressed
Tizanidine Hcl	Tizanidine Hcl	29	suppressed
Azithromycin	Azithromycin	28	11
Prednisone	Prednisone	28	11
Bumetanide	Bumetanide	26	suppressed
Lansoprazole	Lansoprazole	25	suppressed
Mirabegron Er	Mirabegron	25	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Oxcarbazepine	Oxcarbazepine	24	suppressed
Belbuca	Buprenorphine Hcl	23	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	23	suppressed
Ingrezza	Valbenazine Tosylate	21	suppressed
Lorazepam	Lorazepam	21	suppressed
Oxycodone Hcl	Oxycodone Hcl	21	suppressed
Tramadol Hcl	Tramadol Hcl	21	suppressed
Clonazepam	Clonazepam	20	suppressed
Celecoxib	Celecoxib	19	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Estradiol	Estradiol	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	19	suppressed
Novofine 32	Pen Needle, Diabetic	18	suppressed
Ondansetron Odt	Ondansetron	18	11
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	18	suppressed
Amiodarone Hcl	Amiodarone Hcl	17	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	17	suppressed
Lidocaine	Lidocaine	17	suppressed
Prednisolone Acetate	Prednisolone Acetate	17	suppressed
Risperidone	Risperidone	17	suppressed
Atenolol	Atenolol	16	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	16	suppressed
Calcitriol	Calcitriol	16	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Lumigan	Bimatoprost	16	suppressed
Terazosin Hcl	Terazosin Hcl	16	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Cilostazol	Cilostazol	15	suppressed
Letrozole	Letrozole	15	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	15	suppressed
Tradjenta	Linagliptin	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	14	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	14	suppressed
Midodrine Hcl	Midodrine Hcl	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	13	suppressed
Buprenorphine	Buprenorphine	13	suppressed
Dexlansoprazole Dr	Dexlansoprazole	13	suppressed
Dulera	Mometasone/Formoterol	13	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	13	suppressed
Amantadine	Amantadine Hcl	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Insulin Degludec Pen (U-100)	Insulin Degludec	12	suppressed
Methadone Hcl	Methadone Hcl	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Ranolazine Er	Ranolazine	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Teriparatide	Teriparatide	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Testosterone Cypionate	Testosterone Cypionate	11	suppressed
Trospium Chloride	Trospium Chloride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error